Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
ACS Infectious Diseases|May 10, 2023
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract LibraryLucero Martínez-Fructuoso, S J Ryan Arends, Vitor F Freire, et al.
NPJ Precision Oncology|November 5, 2025
DeepTarget predicts anti-cancer mechanisms of action of small molecules by integrating drug and genetic screensSanju Sinha, Neelam Sinha, Marlenne Perales, et al.
The Journal of Infectious Diseases|February 11, 2020
Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus ChallengeMichael K Lo, Jessica R Spengler, Lauren R H Krumpe, et al.
Journal of Natural Products|October 22, 2021
Contemporary Approaches to the Discovery and Development of Broad-Spectrum Natural Product Prototypes for the Control of CoronavirusesGeorge S Hanna, Yeun-Mun Choo, Ryan Harbit, et al.
Nature Communications|September 26, 2018
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivoNina Derby, Manjari Lal, Meropi Aravantinou, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Positive Selection Screen for Natural Product β-Catenin InactivatorsMatthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Journal of Medicinal Chemistry|June 6, 2025
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase InhibitorsLin Du, Brice A P Wilson, William J Moore, et al.
Plos One|January 20, 2022
Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gelNatalia Teleshova, Marla J Keller, José A Fernández Romero, et al.
Nature Communications|February 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Yean Kim, Berkley E Gryder, Ranuka Sinniah, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2023
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2Jordana Muñoz-Basagoiti, Fábio Luís Lima Monteiro, Lauren R H Krumpe, et al.
Pageof 14